| Literature DB >> 25525621 |
Tomasz Kryczka1, Edward Wylęgała2, Dariusz Dobrowolski2, Anna Midelfart3.
Abstract
BACKGROUND: The human eye is a complex organ whose anatomy and functions has been described very well to date. Unfortunately, the knowledge of the biochemistry and metabolic properties of eye tissues varies. Our objective was to reveal the biochemical differences between main tissue components of human eyes.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25525621 PMCID: PMC4265547 DOI: 10.1155/2014/546192
Source DB: PubMed Journal: ScientificWorldJournal ISSN: 1537-744X
Figure 1Representative HR MAS 1H NMR spectra of the intact human eye tissues. (a) cornea, (b) ciliary body, (c) iris, (d) lens, and (e) retina. The ppm values were assigned using sodium [2,2,3,3-d4]3′-trimethylsilylpropionate (TSP) as the reference substance at 0 ppm. Ac: acetate; Ala: alanine; Arg: arginine; Asc: ascorbate; ATP: adenosine triphosphate; But: butyrate; Ch: choline; Cr: creatine; For: formate; α -Glc: α-glucose; β -Glc: β-glucose; Glu: glutamate; Gln: glutamine; GMP: guanosine monophosphate; GPC: glycerophosphocholine; GSH: glutathione; His: histidine; h-Tau: hypo-taurine; Ile: isoleucine; Lac: lactate; Leu: leucine; m-In: myo-inositol; Met: methionine; Phe: phenylalanine; P-Ch: phosphocholine; P-Cr: phosphocreatine; Su: succinate; Tau: taurine; Tyr: tyrosine; Val: valine; ppm: parts per million.
Figure 2Principal component analysis of human eye tissues. (a) Score plot of the 1st versus the 2nd principal component (PC1 versus PC2) of 1H NMR spectra. The groupings of the samples were marked with colorful ellipses. (b) Loading profile of the principal components of the 1H NMR spectra of the eye tissues. Metabolites described in lower cases in the loading profile indicate negligible influence of these compounds on the grouping pattern. The biochemical compounds that served as PC1 were marked with the square frames. The biochemical compounds that served as PC2 were underlined. For metabolite labels see legend for Figure 1.
Figure 3The contents of assigned biochemical compounds in various eye tissues. (a) amino acids; (b) nonamino acid compounds. Data are means ± SEM of HR MAS 1H NMR peak integrals divided by tissue wet weight; * P < 0.05 versus the respective cornea group value; # P < 0.05 versus the respective retina group value; X—no detectable metabolite peak in the respective NMR spectra. For metabolite labels see legend for Figure 1.
Statistical significance of biochemical differences between the eye tissues.
| Metabolite | Homogeneity | Normality | Type of analysis | Cornea-CB*** | Cornea-iris*** | Cornea-lens*** | Cornea-retina*** | CB-retina*** | Iris-retina*** | Lens-retina*** |
|---|---|---|---|---|---|---|---|---|---|---|
| Ac | −* | +** | AW | − | − | − | − | − | − | − |
| Ala | +* | −** | KW | + | + | + | + | − | − | − |
| Arg | − | + | AW | − | − | − | − | − | − | − |
| Asc | + | + | A | + | + | − | + | − | − | + |
| ATP | − | + | AW | + | + | + | + | − | − | − |
| But | + | + | A | n/a | n/a | n/a | n/a | − | − | n/a |
| Ch | − | + | AW | − | − | n/a | + | − | − | n/a |
| Cr | + | − | KW | + | + | + | + | − | − | − |
| For | − | + | AW | + | + | + | + | − | − | − |
| GPC | + | + | A | + | + | + | n/a | n/a | n/a | n/a |
| Gln | − | + | AW | + | − | − | + | + | − | − |
| Glc | − | + | AW | n/a | n/a | + | n/a | n/a | n/a | n/a |
| Glu | − | + | AW | n/a | n/a | + | + | n/a | n/a | − |
| GMP | − | + | AW | n/a | n/a | n/a | n/a | − | + | n/a |
| GSH | − | − | − | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| His | + | + | A | − | n/a | − | n/a | n/a | n/a | n/a |
| h-Tau | + | + | A | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Ile | + | − | KW | + | − | + | + | − | − | + |
| Lac | − | + | AW | + | + | − | + | − | − | + |
| Leu | − | + | AW | + | + | − | − | − | − | − |
| Met | + | + | A | n/a | n/a | n/a | − | n/a | n/a | n/a |
| m-In | − | + | AW | + | + | + | + | + | + | − |
| P-Ch | − | + | AW | n/a | n/a | n/a | n/a | − | − | − |
| P-Cr | + | + | A | n/a | n/a | n/a | n/a | − | − | + |
| Phe | + | + | A | − | − | − | − | − | − | − |
| Su | + | − | KW | + | n/a | + | − | + | n/a | − |
| Tau | − | + | AW | − | − | − | + | + | − | + |
| Tyr | − | + | AW | − | − | + | − | − | − | − |
| Val | + | + | A | − | − | − | − | − | − | − |
*homogeneity of the groups (+/−, yes/no); **normality of the distribution within the groups (+/−, yes/no); ***statistical significance of differences between the groups of samples (+/−, positive/negative); A: one-way analysis of variance (ANOVA); AW: ANOVA with method of Welch for treating unequal variances; K: the Kruskal-Wallis test; n/a: not applicable due to the lack of data for one or both groups of samples; CB: ciliary body. For metabolite labels see legend for Figure 1.